Merck's pneumococcal vaccine showed strong immune responses in children and teens who are at higher risk of serious illness in a late-stage study, the drugmaker said on Thursday. The shot, Capvaxive, ...
An additional dose of a pneumococcal vaccine, either 23-valent pneumococcal polysaccharide vaccine (PPV23) or 20-valent pneumococcal conjugate vaccine (PCV20), for new care home residents upon entry ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results